A retrovirus vector was constructed from the genome of avian erythroblastosis virus ES4. The v-erbA sequences of avian erythroblastosis virus were replaced by those coding for neomycin phosphotransferase, creating a gag-neo fusion protein which provides G418 resistance as a selectable marker. The v-erbB sequences following the splice acceptor were replaced by a cloning linker allowing insertion of foreign genes. The vector has been tested in conjunction with several helper viruses for the transmission of G418 resistance, titer, stability, transcription, and the transduction and expression of foreign genes in both chicken embryo fibroblasts and the QT6 quail cell line. The results show that the vector is capable of producing high titers of Neor virus from stably integrated proviruses. These proviruses express a balanced ratio of genome length to spliced transcripts which are efficiently translated into protein. Using the Escherichia coli j-galactosidase gene cloned into the vector as a test construct, expression of enzyme activity could be detected in 90 to 95% of transfected target cells and in 80 to 85% of subsequently infected cells. In addition, a cDNA encoding the avian erythrocyte band 3 anion exchange protein has been expressed from the vector in both chicken embryo fibroblasts and QT6 cells and appears to function as an active, plasma membrane-based anion transporter. The ectopic expression of band 3 protein provides a visual marker for vector function in these cells.
Recombinant retroviruses have proven to be a highly efficient means of delivering foreign genes into cultured cells (12, 41, 42) or organisms (31, 52) . The most widely used systems employ replication defective murine leukemia virusbased vectors and complementing packaging cell lines which allow transcapsidation of vector RNAs into viral particles for infecting most types of mammalian cells (9, 17, 63) . In the avian system, replication-defective retrovirus vectors have mainly been constructed for specific experimental purposes (18, 43, 53) , though some have been adapted for general use (6, 16) . Replication-competent vectors based on Rous sarcoma virus (RSV; 29, 55) have been constructed with the viral src sequence replaced by a cloning site for cDNAs. These vectors, however, have a limited cloning capacity, making them unsuitable for the insertion of a selectable marker plus a gene of interest. Finally, three packaging cell lines that are based on avian leukosis virus and that provide the functions required in trans for the encapsidation of defective recombinant vector-derived RNAs have been reported (13, 56, 60) . All harbor Rous-associated virus type 1 (RAV-1) proviruses, with partial deletions in the packaging (t,) sequences. Though other modifications to the RAV-1 genome were made, in two of these lines (56, 60) clones which produced high titers of virus also released replicationcompetent helper virus as a result of recombination. The other packaging line (13) was created by separating helper functions on two independent plasmids, reducing the risk of recombinant helper virus production.
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We report here the development of a flexible avian erythroblastosis virus ES4 (AEV-ES4)-based vector which contains all of the sequences known to be required for packaging of viral RNAs (11) , a selectable marker (neo), and a large cloning capacity. The vector is capable of sustained production of high titers of recombinant virus and stable, efficient expression of cloned sequences when transfected into chicken embryo fibroblast (CEF) or QT6 cells. It can be used in conjunction with several of the avian leukosis virus helper viruses or packaging cell lines.
We have used the Escherichia coli lacZ gene cloned into the vector pSFCV to test parameters such as transduction and expression of cloned sequences. We have shown that the recombinant 13-Gal gene-carrying proviruses efficiently express 1-Gal activity in up to 95% of transfected target cells and in up to 85% of infected target cells.
In addition, a eucaryotic cDNA has been inserted to test the vector. This cDNA encodes the chicken band 3 anion transport protein, which catalyzes the exchange of HC03-and Cl-at the erythrocyte plasma membrane and also functions as an anchor for the erythroid cytoskeleton. In the chicken, band 3 protein is encoded by two distinct polypeptides (30) generated by alternative initiation and splicing (34, 35) . The band 3 protein transduced by our vector produces only one of these polypeptides yet appears to function as an active ion transporter correctly situated in the plasma membrane of these cells.
MATERIALS AND METHODS
Cells and culture. CEF were prepared from 11-day-old SPAFAS embryos (Lohmann GmbH, Cuxhaven, Federal FIG. 1 . Schematic representation of pSFCV-neo and pSFCV-LE vectors, showing the location of rare or unique restriction sites, nucleotide numbers (marked every 1,000 bp), locations of predicted genomic and subgenomic RNAs, location of retroviral sequences, the gag-neo fusion protein coding sequence (G418 resistance), splice donor and acceptor sites, and cloning polylinker. (A) pSFCV-neo, a 6,883-nt vector into which the band 3 protein coding sequence has been introduced. pSFCV-BIIIR is a 3.1-kb band 3 protein cDNA inserted into the EcoRI site of pSFCV-neo. pSFCV-BIIIW is the same sequence cloned in the opposite orientation. The 3.3-kb p-Gal gene was cloned into pSFCV-neo at the HindlIl site in the construct pSFCV-p. (B) Modified vector pSFCV-LE with a single 5' LTR and an 88-bp oligonucleotide inserted between the splice acceptor and polylinker. The vector pSFCV-LE containing a 3.14-kb p-Gal insert at the Hindlll site is the plasmid pSFCV-Blue. S.A., splice acceptor; S.D., splice donor; B, BamHI; Bg, BgIl; Bx, BstXI; C, ClaI; H, HindlIl; K, KpnI; M, BsmI; N, NotI; P, PstI; Pv, PvuI; S, Sfil; V, EcoRV; X, XbaI. The arrows on the inserts show the location of AUG and the direction of transcription.
Republic of Germany) as previously described (23) . Both CEF and quail QT6 (44) cells were grown in Dulbecco modified Eagle medium supplemented with 4% fetal calf serum, 2% chicken serum, and 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; pH 7.3). Selection for Neor cells was done in medium containing 0.8 mg of G418 (Geneticin; Sigma Chemical Co.) per ml (wt/vol) for CEF and 1.0 mglml for QT6 cells. The Q2 and Q4 packaging cell lines were maintained as described elsewhere (60) and otherwise treated as described for QT6 cells. The Isolde packaging line was maintained as recommended elsewhere (13) and otherwise treated as described for QT6 cells.
Vector construction. pSFCV-neo (Fig. 1A) was constructed from AEV clones 10 and 11 (14, 21, 64, 66) , representing unintegrated circular viral DNA, and inserted into plasmid pUC19 by standard methods (40) . The pUC19 polylinker was removed and replaced with NotI linkers. AEV-derived fragments were then cloned into the plasmid NotIl site, and the vector was constructed with the sequences outlined in Table 1 Table 3 ).
Southern and Northern (RNA) analyses. Genomic DNA was prepared from 10-cm plates of confluent cells, digested with BstXI or BgIII, subjected to electrophoresis on 0.8% agarose gels, and transferred to nylon membranes (Hybond N; Amersham Corp.). Southern blots were probed with a 32P-labeled neo fragment prepared by random hexamer labeling (19) (Multiprime Labeling System; Amersham). Poly(A)+ RNA for Northern analysis was prepared as previously described (65) from 15-cm plates of semiconfluent cells. Poly(A)+ RNA (1 to 2 ,ug) was electrophoretically separated on 1% agarose-formaldehyde gels containing MOPS (morpholinepropanesulfonic acid, pH 7.0) at 140 V for 4 to 5 h. The RNA was transferred to membranes and hybridized with 32P-labeled neo, env, or chicken band 3 protein fragments derived from pSFCV-BIIIR. P-Gal assays. In situ assays for n-Gal production were performed on glutaraldehyde-fixed subconfluent plates of SFCV-Blue-transfected or infected CEF or Isolde cells according to a protocol described by Dannenberg (15, 50) . Blue colonies were counted after 6 to 10 h. To determine the percentage of colonies expressing P-Gal, these plates were rinsed in phosphate-buffered saline, treated with acetonemethanol, and stained with gentian violet to assess the total number of Neor colonies. Only blue colonies of uniform size (P-Gal) were scored.
Protein analyses. Immunoprecipitation of 35S-labeled cell extracts with gag and band 3 protein antibodies was done as previously described (3), using protein A-Sepharose (Pharmacia) and monoclonal antibodies MCA2E (67) to chicken band 3 protein, MC4.2.A5 (25) to chicken hemoglobin, and M3CZC (26) to viral gag (p19) polypeptides. Labeled extract (107 cpm) was used for each immunoprecipitation.
For immunofluorescence studies, fibroblasts were detached from the culture plastic with EDTA and fixed in paraformaldehyde. Anti-chicken band 3 protein monoclonal antibody coupled to fluoroscein isothiocyanate-goat antimouse immunoglobulin was used to visualize the location of the band 3 protein, as described elsewhere (68) .
Assay for anion transporter function. Anion transporter activity was tested in two ways. First, SFCV-BIIIR-and SFCV-BIIIW-infected (Neo) cells were cultured for 24 h in the presence or absence of 0.4 mM DIDS (diisothiocyanodihydrostilbene-2.2' disulfonic acid; Sigma), a specific inhibitor of band 3 protein activity. The presence of vacuoles was VOL. 64, 1990 at CSIC-PUBLICACIONES ELECTRONICAS on April (4, 20, 22) . Also, the virus is efficiently packaged when pseudotyped with a variety of helper viruses, yielding titers of 105 to 106 infectious particles per ml (20, 22) . In pSFCV-neo, the LTRs and gag sequences originate from the cloned AEV genome (66; Fig.  1 ). Because packaging sequences, a splice donor site, and other functions (11) pSFCV-LE (Fig. 1B) was constructed from pSFCV-neo by partial BstXI digestion and religation to create a single upstream LTR. In addition, a modification was made to ensure the efficient translation of inserted sequences. In pSFCV-neo, the presence of a stop codon following the splice acceptor prevents the fusion of gag sequences to cloned genes. To provide a proper distance (37) Integration and maintenance of SFCV-neo provirus. To examine the status of the SFCV provirus, virus supernatants were used to infect CEF or QT6 cells, and Neor pools (CEF) or clones (QT6) of cells were isolated and expanded for Southern analysis. BstXI, which cuts in the retroviral LTRs, and BglII, which cuts once in SFCV, were used to determine integration sites and copy number, respectively, of the SFCV provirus in infected cells. The SFCV-neo provirus was integrated and stably maintained at one to three copies per cell in all cell populations (Fig. 2) . The probe used for this purpose was a 910-bp neo fragment. In some lanes (SFCV-P*), 10 pg (-1 copy equivalent) of pSFCV-neo plasmid DNA was included in the restriction digests for comparison. The first lane contains BstXI-cleaved pSFCVneo DNA alone.
Expression of P-Gal activity by pSFCV-Il and pSFCV-Blue.
Transfected Neor populations of CEF cells expressing SFCV-P were assayed in situ for P-Gal activity. In general, 1 to 10% of the cells expressed enzyme activity, and clones of cells remained uneven, with a fraction losing or gaining expression as the cells were passaged for short periods. In an attempt to remedy the failure of pSFCV-1 to efficiently express 13-Gal activity, the vector was modified as described above. The new version, pSFCV-Blue, was then assayed in two sets of experiments for its ability to transduce 1-Gal activity to transfected or infected cells (Tables 2 and 3 ). CEF or Isolde cells were transfected with pSFCV-Blue and plated sparsely enough to distinguish individual colonies following G418 selection. These were assayed in situ for 1-Gal production and later stained with gentian violet to count all Neor colonies. In two separate transfections, 106 of 117 (90%) and 50 of 56 (89%) of Neor CEF colonies were positive for 13-Gal activity. Of 22 isolated Isolde clones, all were positive for 13-Gal activity, with 18 clones being >90% positive. To assess the ability of SFCV-Blue viruses to transduce 13-Gal activity, supernatants of the 18 transfected Isolde cell clones were used to infect fresh CEF cells. Of the clones tested, all infected CEF pools scored positive by in situ staining. About 90% of the infected cells in any pool were 1-Gal positive. When these CEF infectants are grown sparsely to isolate colonies, >80% of the Neor colonies were 13-Gal positive, depending on the virus stock. These results are in stark contrast to the weak 1-Gal activity transduced by our previous construct, pSFCV-1.
Expression of RNAs from SFCV-neo LTR. Northern analysis of SFCV-neo-infected CEF or QT6 cells was used to determine the relative amounts of SFCV genomic and spliced RNAs present in infected cells. A neo probe detected the full-length genomic RNA in the SFCV-neo-and SFCV-BIIIR-infected cells (Fig. 3 ). An env-specific probe detected all RNAs of vector and helper virus origin. Cells containing SFCV-neo proviruses without inserts produced the 3.0-kb full-length SFCV-neo transcript, but they all failed to produce the expected spliced transcript of 1.25 kb. Instead, a 2-kb cryptically spliced RNA was observed. In cells harboring SFCV proviruses containing foreign sequences (Fig. 3,  band 3 ), the relative amount of this cryptically spliced RNA was lower than in SFCV-neo-infected cells, but an additional cryptically spliced mRNA was seen at 1.8 kb. In cells harboring the SFCV-BIIIR construct, the probe for band 3 detected mainly the 6.1-kb full-length RNA, the 4.35-kb spliced subgenomic RNA, and the cryptic 1.8-kb RNA. The SFCV-neo 2-kb cryptic splice could result from the utilization of a potential cryptic acceptor site created at the gag-neo junction. The 1.8-kb cryptic splice could result from splicing within the band 3 protein coding sequences. The presence of these alternatively spliced mRNAs did not seem to interfere with the production of sufficient neo to provide G418 resistance or the production of band 3 protein from the correctly spliced mRNA. Experiments to determine the origin of these cryptic splice points are currently under way as part of an attempt to eliminate the points from the SFCV constructs.
Expression of SFCV gag-neo protein. Immunoprecipitation of gag-related proteins from SFCV-BIII-infected cells (Fig.  4) showed two specific products. The pr769ag protein represents the precursor gag protein expressed by the helper virus, whereas the smaller gag polypeptide is the vectorderived gag-neo fusion protein of 55,000 Mr. The observed size of the p55gagneo protein is in agreement with the estimated size of a 482-amino-acid gag-neo fusion protein of 53,000 daltons. Though the amount of p55gag-neo protein was low compared with that of pr76gag of the helper virus, it was sufficient to provide Neor, even at concentrations of 3 mg of G418 per ml, which is necessary for the selection of erythroblast cultures (data not shown).
Band 3 protein expression from SFCV in fibroblasts. The cDNA encoding chicken erythrocyte band 3 protein was successfully expressed in fibroblasts using the pSFCV-neo vector. Immunoprecipitation of band 3 protein (Fig. 4) in CEF cells transfected with SFCV-BIIIR and RCAN-BHpol showed a strong band in the 95-kDa molecular size range which is absent from SFCV-BIIIW (opposite orientation)-transfected cells and similar to the band for the native protein immunoprecipitated from EGF receptor-transformed erythroblasts (33) . This size is in agreement with the established molecular weights of erythrocyte band 3 polypeptides of 100,000 and 105,000 (doublet). The cDNA used to express band 3 protein in the SFCV-BIIIR construct represents only one of these two polypeptides, which are generated by alternative initiation and splicing of mRNAs (34, 35) .
Indirect immunofluorescence of CEF expressing the SFCV-BIII constructs (Fig. SA) using a band 3-specific monoclonal antibody showed a bright ring of fluorescence , an SFCV-BIIIR-infected QT6 cell clone, or helper virus-infected QT6 cells was analyzed with a battery of probes. An env probe was used to detect all viral transcripts, a neo probe was used to detect SFCV-specific transcripts, or a chicken band 3 probe was used to detect band 3 transcripts. The marker (lane M) was an end-labeled HindIII-EcoRI digest of DNA. The arrows on the left indicate the migration of the various RNAs: helper virus genomic and subgenomic transcripts, 7.8 and 2.7 kb; SFCV-neo-derived genomic RNA, 3.0 kb; cryptically spliced RNA, 2.0 kb; band 3 protein-derived genomic RNA, 6.1 kb; subgenomic RNA, 4.4 kb; cryptically spliced RNAs, 4.6 and 1.8 kb. Lane SFCV-BIIIR* represents a shorter exposure of the SFCV-BIIIR lane to its left. The 32P-labeled probes used for this purpose were a 580-bp env fragment, a 910-bp neo fragment, and a 3.0-kb band 3 protein fragment, all derived from SFCV-BIIIR. located at the periphery of cells transfected with SFCV-BIIIR DNA and absent in SFCV-BIIIW counterparts. This is consistent with the plasma membrane localization of band 3 protein in erythrocytes and shows that the vector-encoded protein behaves in a manner consistent with its role in vivo. All Neor clones or pools of band 3 protein-transfected or infected cells thus far analyzed have produced band 3 protein by one or more of the three criteria we use, i.e., immunoprecipitation, immunofluorescence, or vacuolization.
CEFs infected with SFCV-BIIIR, but not SFCV-BIIIW, viruses become highly vacuolated. In order to assess whether this was due to the ion exchange activity of the ectopically expressed band 3 protein, two experiments were performed. The first was to alter the bicarbonate content of the cell culture medium, which can be used to modulate anion transport activity. After 48 h in normal pH 7.2 medium, the vacuoles remained (Fig. 5B) , but when the same cells were grown in pH 8.0 medium in a parallel experiment, the vacuoles disappeared. There was no change in SCFV-BIIIW-transfected cells under the same conditions. All cells grew normally at both pH values.
Second, we used the compound DIDS (a stilbene disulfonate derivative), which functions as an inhibitor of band 3 protein by irreversibly binding to the extracellular domain of the protein and blocking anion transport. The addition of 0.4 mM DIDS to the cell culture medium caused, within 24 h, the elimination of vacuoles from SFCV-BIIIR-transfected cells while having no apparent effect on their growth (Fig.  5C ). There was no effect on SFCV-BIIIW-transfected cells under the same conditions (data not shown). These results also indicated that the ectopically expressed band 3 protein was located in the plasma membrane in the correct orientation and mediated anion transport, as does the endogenous erythrocyte protein. (38, 54) . In addition, several cis-acting elements outside of the viral LTRs were also retained, as discussed below.
Packaging sequences (4I) of the avian retroviruses are found at several points on the viral genomic RNA. An important * sequence lies in the untranslated leader region between U5 and the start of gag (32) . This -30-bp sequence is located -250 bp from the 5' end of the genomic RNA and constitutes a major part of the sequences required for efficient encapsidation of viral RNAs; it overlaps in part with sequences affecting viral replication and protein translation (5, 46, 49) . In addition, another important packaging signal lies within the structural gene for gag (51) , about 150 bp downstream of the splice donor site. Also, some of the sequences directly involved in the genome dimerization step necessary for encapsidation are located in this region (5) . Finally, noncoding sequences 3' of env are thought to be involved in viral genome assembly (27, 58) for packaging. SFCV-neo was designed to encompass all of the sequences mentioned above.
In the avian sarcoma and leukosis viruses, other cis-acting sequences overlap the gag coding sequences, and they are retained in SFCV-neo. These sequences affect splicing (39, 57, 61) , contain determinants of viral tropism (53) , and also make up a second important enhancer region (1, 8, 61) . Recent studies using in vitro chloramphenicol acetyltransferase assays show that a series of deletions in gag, extending from the 3' end, result in a continual reduction in transcriptional activity compared with that of the intact sequence (1) . In mutations extending beyond a critical region, transcription is markedly reduced. This enhancer region, required for efficient viral transcription in some cell types (1, 61) , is located just upstream of the gag-neo junction in pSFCV-neo (nt 2243).
To avoid promoter interference by competing transcriptional regulatory domains (18), we chose to express inserted sequences from spliced, subgenomic RNAs in SFCV-neo. RSV efficiently utilizes multiple splice acceptors in this context (env and src). The splice donor site in SFCV is located after the sixth codon in gag, and the splice acceptor site is that of the v-erbB gene, both derived from AEV. In the context of SFCV, these sequences functioned efficiently to direct the splicing of subgenomic mRNAs when cloned inserts were present in the SFCV-neo polylinker. In the absence of cloned sequences, the expected subgenomic mRNA could not be detected, and cryptically spliced RNAs were present in all SFCV-neo variants. These cryptic splices probably result from the introduction of foreign sequences, such as neo, into the retroviral genome and do not seem to interfere with splicing or translation of the correct mRNAs in pSFCV-transfected or infected cells. Cryptic splicing has also been noted in murine retrovirus vectors (7; personal communication); the aberrant splicing seems to have no effect on expression of correctly spliced RNAs. However, experiments are currently under way to determine the sites of these aberrant splice points and remove them from pSFCV. The SFCV polylinker is immediately downstream of the SFCV splice acceptor and contains first a stop codon, closing the reading frame initiated in the RNA leader; then restriction sites for HindIll, EcoRV, BglI, SfiI, ClaI, XbaI, and EcoRI; and then stop codons in all frames. By using adaptor plasmids which carry the RSV src splice acceptor, leader sequence, and an adjoining polylinker on a ClaI fragment (25) , a second spliced mRNA could potentially be produced by SFCV-neo proviruses.
In pSFCV-LE, a further modification has been made in the region near the splice acceptor. We have inserted a modified, synthetic 88-bp human EGF receptor fragment (nt 105 to 186) to provide a spacer between the stop codon and the beginning of the polylinker. This sequence, in an unmodified form, has been previously used by our lab to produce about 106 EGF receptor molecules per cell from an AEV vector in a similar context (33) . It has been shown that a minimum sequence is required between a stop codon and an in-frame AUG to allow efficient ribosomal reinitiation (37) . The original SFCV-P-Gal construct (SFCV-p) was a 3.3-kb fragment cloned into the first (HindIII) site of the polylinker. SFCV-1 produced weak, erratic p-Gal activity in transfected and infected cells, although 3-Gal-specific subgenomic RNA was abundant in these cells (data not shown). However, when the P-Gal gene was cloned into the Hindlll site of the 64, 1990 at CSIC-PUBLICACIONES ELECTRONICAS on April 30, 2010 jvi.asm.org Downloaded from modified SFCV-LE vector, enzyme activity was detected in >90% of Neor transfected cells even after several generations in culture.
The potential cloning capacity of SFCV-neo can be estimated from RSV. This virus encodes a 9.3-kb genomic RNA, and infectious mutants with a genome length of up to 10.1 kb exist (48) . This would allow, by analogy, cloning of between 6.4 and 7 kb of foreign sequence into SFCV-neo without impairing the efficiency of packaging. Experiments to test this are currently under way: two genes expressed from separate splice acceptors will be inserted into pSFCV-LE. The total insert size will be 6.5 kb.
The fusion of gag to neo in SFCV-neo did not affect the ability of the neomycin phosphotransferase protein to provide Neor in the presence of high concentrations of G418, and the cis-and trans-acting activities present in gag appeared to be undisturbed. Consequently, all of the important regulatory signals encoding splicing, enhancer, and sequences were retained in the gag region, while the neo portion efficiently provided G418 resistance to infected cells, as shown by titration experiments. In SFCV-neo, both the unspliced and the spliced mRNAs were efficiently translated into protein, as shown by immunoprecipitation of the gagneo and band 3 proteins.
We have used the E. coli lacZ (a-Gal) gene to test the features of vector function. Using two separate 13-Gal constructs, we have tested expression of ,8-Gal protein by in situ analysis and analyzed virus titers from SFCV-1-gal-transfected cells. Using the SFCV-Blue construct in transfection experiments with both QT6 and CEF cells, we have shown that enzyme activity is efficiently expressed in >90% of G418-selected clones or pools of cells. When supernatants from three of these cell clones were used to infect CEF cells, >80% of colonies were ,8-Gal positive Neor. SFCV-Blue has also been used to express 13-Gal in erythroblasts (data not shown), and >95% of the infected Neor erythroblasts expressed enzyme activity by in situ analysis. SFCV-,-RCAN-BHpol-cotransfected QT6 cells efficiently produced 106 Neor units per ml of virus, and SFCV-Blue-RCANBHpol-cotransfected CEF cells yielded similar titers of 2 x 106 to 4 x 106 Neor units per ml.
We chose the cDNA for the erythrocyte anion transporter to analyze the expression of a eucaryotic gene from the SFCV-neo vector. We are also interested in the role of band 3 protein repression by v-erbA in the AEV transformation of erythroblasts (68) . The SFCV viruses are intended for use in erythroblasts as well as fibroblasts, and it was anticipated that the ectopic expression of band 3 protein in fibroblasts could be readily monitored. The expression of the anion transporter protein from the SFCV-BIIIR provirus, in fact, caused vacuolization of the infected fibroblasts. Recently published data from studies using a neuronal homolog of murine band 3 protein expressed in COS cells (36) showed that ectopic anion transporter expression caused intracellular acidification. This was also seen when murine erythroid band 3 protein was expressed in Xenopus oocytes (2) . Thus, under normal culture conditions, the anion transporter exchanges intracellular HC03-for extracellular Cl-in a manner dependent on the bicarbonate and chloride content of the medium. In fibroblasts infected with SFCV-BIIIR viruses, vacuolization was presumably due to intracellular acidification, since this phenotype could be abolished by growing the cells in alkaline medium. An interpretation of this is that the addition of extra bicarbonate to increase the pH of the medium altered the anion exchange activity, thereby relieving the vacuolization. This hypothesis is supported by the experiments with DIDS, which irreversibly blocked band 3 protein anion exchange activity. When DIDS was added to the culture medium, cellular vacuolization in band 3 protein-containing fibroblasts was relieved. Effects of intracellular acidification were probably relieved in SFCV-BIIIR cells by sequestration of acidic groups in vacuoles, though this has not been directly tested. The presence of band 3 protein and the multiple, large vacuoles did not appear to affect the growth rate of the cells. This band 3 protein-associated vacuolization has also been reported for erythroblasts (68) . In these experiments, erythroblasts were infected with an AEV virus which harbors a defective v-erbA; the cells were vacuolated when cultivated in medium of the inappropriate pH or lacking DIDS, whereas this phenotype was absent in pH-adjusted medium. Furthermore, the vacuolization in erythroblasts could be abolished by expression of the normal v-erbA oncogene, which completely repressed band 3 protein gene expression.
The phenotype induced by the ectopic expression of band 3 protein activity at the plasma membrane of infected fibroblasts provided a visual marker for the correct transcription, translation, transport, and stability of sequences transduced by SFCV-neo. Though the band 3 anion exchange protein is encoded by two polypeptides in avian cells, we have shown that the expression of one of these proteins is sufficient for the proper transport, plasma membrane localization, and expression of anion exchange activity in SFCV-BIIIR-infected CEFs. We estimate that the amount of band 3 protein expressed in these fibroblasts is similar to the abundance of native band 3 in mature erythrocytes (data not shown), judged by immunoprecipitation experiments.
